LD Micro 12th Annual Main Event Investor Conference

Authors: O’Connor S
Keywords: 12th Annual LD Micro Main Event, investor relations, LD Micro Conference
Division: PBPK

Serving All Stages of the Development Process

Products and services span the entire drug development process from discovery to approval

Software Product Portfolio

  • Physiologically-based pharmacokinetic (PBPK) modeling platform
  • Predicts 140+ properties of chemical formulations
  • Quantitative Systems Toxicology (QST) and Quantitative Systems Pharmacology (QSP) for analyzing certain biological or disease states
  • Cloud-based web application to organize, process, maintain & communicate data and results over the duration of a drug development program

Consulting Services

  • Support clients through entire drug development process from sketching chemicals to regulatory filings
  • Provide multi-disciplinary modeling and simulation support:
    • PBPK modeling
    • Population/PK analyses
    • Pharmacodynamic modeling
    • NONMEM analysis
    • Quantitative systems pharmacology and toxicology
    • Quantitative structure-activity relationship modeling
    • Data assembly and preparation of reports

By Shawn O’ Connor

LD Micro 12th Annual Main Event, December 10-12, 2019